Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0000950170-25-078328
Filing Date
2025-05-28
Accepted
2025-05-28 16:05:20
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B3 apvo-2025-prosup-424b3-2.htm 424B3 356108
2 GRAPHIC img94469831_0.jpg GRAPHIC 4507
3 GRAPHIC img94469831_1.jpg GRAPHIC 199177
4 GRAPHIC img94469831_2.jpg GRAPHIC 250435
5 GRAPHIC img94469831_3.jpg GRAPHIC 4507
  Complete submission text file 0000950170-25-078328.txt   989081
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-287244 | Film No.: 25995412
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)